Delivery Order SPE2DB25D3017-SPE2DB25FVJZV
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $5.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Xifaxan 550 mg tablets (60-count packages) under a firm fixed-price arrangement with a ceiling value of $22,475.14. This non-set-aside, competitively awarded delivery order is scheduled for completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count) with a ceiling value of $1,954.87. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xifaxan 550 mg tablets (60-count) under a firm fixed price contract with a ceiling value of $24,364.10 and an ultimate completion date of July 22, 2025. This is a non-set-aside competitive award, with performance to be executed at the vendor's Conshohocken, Pennsylvania location. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,403.14 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). This competitively awarded, firm fixed-price contract is not designated as a set-aside and specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. The contract represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the...
- This federal contract award, valued at $9,027.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25D3002|SPE2DB25FLQMG) for the supply of Xifaxan 550 mg tablets, a medication used to treat various gastrointestinal conditions. The contract has a firm-fixed-price structure and an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract is for the delivery of Xifaxan 550 mg tablets, a pharmaceutical product used to treat various medical conditions. The contract has a completion date of April 15, 2024, and a ceiling value of $24,331.97. Amerisourcebergen Drug Corp is the prime contractor on a larger...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $79,753.90, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of May 21, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- The Defense Logistics Agency awarded a $36,970.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet supplies of Xifaxan 550 mg, an antibiotic medication used to treat traveler's diarrhea and irritable bowel syndrome. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 21, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,431.40 firm fixed price contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The delivery order has an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Xifaxan 550 mg tablets. The contract has a firm fixed price, with a ceiling value of $37,140.56, and an ultimate completion date of September 10, 2024. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...